Jane Robertson

Phase I Clinical Study of AZD2171, an Oral Vascular Endothelial Growth Factor Signaling Inhibitor, in Patients With Advanced Solid Tumors

Joachim Drevs, Patrizia Siegert, Michael Medinger et al. · Journal of Clinical Oncology · 2007 · 302 citations

Efficacy and safety of olaparib monotherapy in germline BRCA1 / 2 mutation carriers with advanced ovarian cancer and three or more lines of prior therapy

Susan M. Domchek, Carol Aghajanian, Ronnie Shapira‐Frommer et al. · Gynecologic Oncology · 2015 · 297 citations · Full text

Endocrine-related Cancer, Medicine, Cancer Management +9

Candidate biomarkers of PARP inhibitor sensitivity in ovarian cancer beyond the BRCA genes

Darren Hodgson, Brian Dougherty, Zhongwu Lai et al. · British Journal of Cancer · 2018 · 225 citations · Full text

Immunogenicity of vaccination against influenza, Streptococcus pneumoniae and Haemophilus influenzae type B in patients with multiple myeloma

Jane Robertson, K.R. Nagesh, SimonN. Jowitt et al. · British Journal of Cancer · 2000 · 206 citations · Full text

Cediranib With mFOLFOX6 Versus Bevacizumab With mFOLFOX6 As First-Line Treatment for Patients With Advanced Colorectal Cancer: A Double-Blind, Randomized Phase III Study (HORIZON III)

Hans‐Joachim Schmoll, David Cunningham, Alberto Sobrero et al. · Journal of Clinical Oncology · 2012 · 206 citations · Full text